Multi-omics in cardiac arrest: a systematic review.

Area of Science:

• Cardiology
• Genomics
• Proteomics
• Metabolomics

Background:

• Cardiac arrest (CA) presents a major public health issue with high mortality rates.
• Current pharmacotherapy for CA is limited, emphasizing the need for prevention and early intervention.
• Omics technologies provide novel insights into CA pathophysiology.

Purpose of the Study:

• To review recent advancements in omics technologies for understanding CA.
• To highlight the role of genetic variations, RNA transcripts, protein profiles, and metabolites in CA.
• To identify potential diagnostic biomarkers and therapeutic targets for CA.

Main Methods:

• Comprehensive literature review of omics studies related to cardiac arrest.
• Analysis of data from genomics, transcriptomics, proteomics, and metabolomics research.
• Synthesis of findings to elucidate the role of molecular variations in CA.

Main Results:

• Omics technologies reveal significant insights into the molecular underpinnings of CA.
• Genetic variations, RNA transcripts, protein profiles, and metabolites are implicated in CA development and progression.
• These advancements pave the way for identifying novel biomarkers and therapeutic strategies.

Conclusions:

• Omics research is crucial for unraveling the complexities of CA.
• Future directions include integrating multi-omics data for a holistic understanding of CA.
• This approach holds promise for developing precision treatment strategies for cardiac arrest.